Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Stern C, Loustaud-Ratti V, Yurdaydin C, Brancaccio G, Jachs M, Reiberger T, Bardou-Jacquet E, Metivier S, Alric L, Colombain L, Meszaros M, Mathurin P, Yardeni D, Etzion O, Neumann-Haefelin C, Douglas M, Poulin S, Bazinet M, Metin RO, Vitale A, Gaeta GB, Schwarz M, Ben-Ali S, Bedoya JU, Testoni B, Zoulim F, Plissonnier ML, Levrero M, Paradis V, Francois S, de Freitas C, Kaysin F, Lecomte L, Morvan C, Schramko J, Bondezi K, Baril MÉ, Brichler S, Gerber A, Gordien E, Mackiewicz V, Dahari H, Svicher V, Chevaliez S, Vaillant A, Bourliere M

Open source

DOI
10.1016/j.jhep.2025.10.029
Published
2026 Mar
Container
Journal of hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jhep.2025.10.029,
  title = {Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.},
  author = {Stern C and Loustaud-Ratti V and Yurdaydin C and Brancaccio G and Jachs M and Reiberger T and Bardou-Jacquet E and Metivier S and Alric L and Colombain L and Meszaros M and Mathurin P and Yardeni D and Etzion O and Neumann-Haefelin C and Douglas M and Poulin S and Bazinet M and Metin RO and Vitale A and Gaeta GB and Schwarz M and Ben-Ali S and Bedoya JU and Testoni B and Zoulim F and Plissonnier ML and Levrero M and Paradis V and Francois S and de Freitas C and Kaysin F and Lecomte L and Morvan C and Schramko J and Bondezi K and Baril MÉ and Brichler S and Gerber A and Gordien E and Mackiewicz V and Dahari H and Svicher V and Chevaliez S and Vaillant A and Bourliere M},
  year = {2026},
  journal = {Journal of hepatology},
  doi = {10.1016/j.jhep.2025.10.029},
  url = {https://doi.org/10.1016/j.jhep.2025.10.029}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.
AU  - Stern C
AU  - Loustaud-Ratti V
AU  - Yurdaydin C
AU  - Brancaccio G
AU  - Jachs M
AU  - Reiberger T
AU  - Bardou-Jacquet E
AU  - Metivier S
AU  - Alric L
AU  - Colombain L
AU  - Meszaros M
AU  - Mathurin P
AU  - Yardeni D
AU  - Etzion O
AU  - Neumann-Haefelin C
AU  - Douglas M
AU  - Poulin S
AU  - Bazinet M
AU  - Metin RO
AU  - Vitale A
AU  - Gaeta GB
AU  - Schwarz M
AU  - Ben-Ali S
AU  - Bedoya JU
AU  - Testoni B
AU  - Zoulim F
AU  - Plissonnier ML
AU  - Levrero M
AU  - Paradis V
AU  - Francois S
AU  - de Freitas C
AU  - Kaysin F
AU  - Lecomte L
AU  - Morvan C
AU  - Schramko J
AU  - Bondezi K
AU  - Baril MÉ
AU  - Brichler S
AU  - Gerber A
AU  - Gordien E
AU  - Mackiewicz V
AU  - Dahari H
AU  - Svicher V
AU  - Chevaliez S
AU  - Vaillant A
AU  - Bourliere M
PY  - 2026
JO  - Journal of hepatology
DO  - 10.1016/j.jhep.2025.10.029
UR  - https://doi.org/10.1016/j.jhep.2025.10.029
ER  -

APA

C, S., V, L., C, Y., G, B., M, J., T, R., E, B., S, M., L, A., L, C., M, M., P, M., D, Y., O, E., C, N., M, D., S, P., M, B., RO, M., A, V., GB, G., M, S., S, B., JU, B., B, T., F, Z., ML, P., M, L., V, P., S, F., C, D. F., F, K., L, L., C, M., J, S., K, B., MÉ, B., S, B., A, G., E, G., V, M., H, D., V, S., S, C., A, V., & M, B. (2026). Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.. Journal of hepatology. https://doi.org/10.1016/j.jhep.2025.10.029

Source records